Scott Durbin - 04 Jan 2022 Form 4 Insider Report for VIVEVE MEDICAL, INC.

Role
Chief Executive Officer
Signature
/s/ Scott Durbin
Issuer symbol
N/A
Transactions as of
04 Jan 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2022, 15:02:23 UTC
Previous filing
17 Dec 2021
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Incentive Stock Option (Right to Purchase) Award $0 +258,000 $0.000000 258,000 04 Jan 2022 Common Stock 258,000 $1.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the "2013 Plan") and received 258,000 incentive stock options on January 4, 2022 (the "Grant Date"). The incentive stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date.